Clinical trial

Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional…

NCT00474708 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed

Key facts

NCT number NCT00474708
Title Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
Official title The Efficacy of Venlafaxine XR (Efexor XR®) Versus SSRIs & Conventional Antidepressants in Depressed Patients Switched From Prior Antidepressants in Psychiatric Outpatient Care Settings in China
Lead sponsor Wyeth is now a wholly owned subsidiary of Pfizer, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Major Depressive Disorder
Intervention type Drug
Interventions Effexor, SSRI
Enrollment 1,151
Start date Apr 1, 2007
Primary completion Mar 1, 2008
Completion Mar 1, 2008
First posted May 17, 2007
Last update posted Mar 5, 2012
Countries China

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies